(S (NP (NP (JJ Recent) (NNS events)) (VP (VBG leading) (PP (TO to) (NP (NP (DT the) (JJ worldwide) (NN pandemic)) (PP (IN of) (NP (NNP COVID-19))))))) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (JJ effective) (NN use)) (PP (IN of) (NP (JJ genomic) (VBG sequencing) (NNS technologies))) (S (VP (TO to) (VP (VB establish) (NP (NP (DT the) (JJ genetic) (NN sequence)) (PP (IN of) (NP (DT this) (NN virus)))))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP (DT the) (NNP COVID-19) (NN pandemic)) (VP (VBZ has) (VP (VBN demonstrated) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (JJ computational) (NNS approaches)) (SBAR (S (VP (TO to) (VP (VB understand) (NP (NP (DT the) (JJ molecular) (NN basis)) (PP (IN of) (NP (DT this) (NN infection)))) (ADVP (RB rapidly))))))))))) (. .))
(S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP present) (NP (NP (DT an) (JJ integrated) (NN approach)) (PP (TO to) (NP (NP (DT the) (NN study)) (PP (IN of) (NP (NP (DT the) (JJ nsp1) (NN protein)) (PP (IN in) (NP (NNP SARS-CoV-1))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ plays) (NP (NP (DT an) (JJ essential) (NN role)) (PP (IN in) (S (VP (S (VP (VP (VBG maintaining) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (JJ viral) (NNS proteins))))) (CC and) (VP (ADVP (RBR further)) (VBG disabling) (NP (DT the) (NN host) (NN protein) (NN expression))))) (, ,) (VP (ADVP (RB also)) (VBN known) (PP (IN as) (NP (DT the) (NN host) (NN shutoff) (NN mechanism))))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP present) (NP (NP (CD three) (JJ independent) (NNS methods)) (PP (IN of) (S (VP (VBG evaluating) (NP (NP (CD two) (JJ potential) (NN binding) (NNS sites)) (VP (VBD speculated) (S (VP (TO to) (VP (VB participate) (PP (IN in) (NP (NP (NN host) (NN shutoff)) (PP (IN by) (NP (NN nsp1))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP have) (VP (VBN combined) (NP (NP (NNS results)) (PP (IN from) (NP (NP (JJ computed) (NNS models)) (PP (IN of) (NP (NNS nsp1)))))) (, ,) (PP (IN with) (NP (NP (NP (NP (JJ deep) (NN mining)) (PP (IN of) (NP (DT all) (VBG existing) (NN protein) (NNS structures)))) (PRN (-LRB- -LRB-) (S (VP (VBG using) (NP (NNP PDBMine)))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (VBG binding) (NN site) (NN recognition)) (PRN (-LRB- -LRB-) (S (VP (VBG using) (NP (NN msTALI)))) (-RRB- -RRB-))))) (S (VP (TO to) (VP (VB examine) (NP (NP (DT the) (CD two) (NNS sites)) (VP (VBG consisting) (PP (IN of) (NP (NNS residues) (JJ 55-59) (CC and) (JJ 73-80)))))))))) (. .))
(S (PP (VBN Based) (PP (IN on) (NP (PRP$ our) (JJ preliminary) (NNS results)))) (, ,) (NP (PRP we)) (VP (VBP conclude) (SBAR (IN that) (S (NP (DT the) (NNS residues) (JJ 73-80)) (VP (VBP appear) (PP (IN as) (NP (NP (DT the) (NNS regions)) (SBAR (WHNP (WDT that)) (S (VP (VBP facilitate) (NP (NP (DT the) (JJ critical) (JJ initial) (NNS steps)) (PP (IN in) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NN nsp1))))))))))))))) (. .))
(S (PP (VBN Given) (NP (NP (DT the) (ADJP (CD 90) (NN %)) (NN sequence) (NN identity)) (PP (IN between) (NP (NP (NN nsp1)) (PP (IN from) (NP (NP (NNP SARS-CoV-1)) (CC and) (NP (NNP SARS-CoV-2)))))))) (, ,) (NP (PRP we)) (VP (VBP conjecture) (NP (NP (DT the) (JJ same) (JJ critical) (NN initiation) (NN step)) (PP (IN in) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NNP COVID-19) (NN nsp1))))))) (. .))
